JPWO2022230494A1 - - Google Patents

Info

Publication number
JPWO2022230494A1
JPWO2022230494A1 JP2023517172A JP2023517172A JPWO2022230494A1 JP WO2022230494 A1 JPWO2022230494 A1 JP WO2022230494A1 JP 2023517172 A JP2023517172 A JP 2023517172A JP 2023517172 A JP2023517172 A JP 2023517172A JP WO2022230494 A1 JPWO2022230494 A1 JP WO2022230494A1
Authority
JP
Japan
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2023517172A
Other languages
Japanese (ja)
Other versions
JP7817249B2 (ja
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of JPWO2022230494A1 publication Critical patent/JPWO2022230494A1/ja
Application granted granted Critical
Publication of JP7817249B2 publication Critical patent/JP7817249B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/41641,3-Diazoles
    • A61K31/4172Imidazole-alkanecarboxylic acids, e.g. histidine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17Amino acids, peptides or proteins
    • A23L33/175Amino acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • A61P37/04Immunostimulants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Mycology (AREA)
  • Nutrition Science (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
JP2023517172A 2021-04-26 2022-03-25 免疫細胞の代謝促進用組成物 Active JP7817249B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2021074323 2021-04-26
JP2021074323 2021-04-26
PCT/JP2022/014256 WO2022230494A1 (ja) 2021-04-26 2022-03-25 免疫細胞の代謝促進用組成物

Publications (2)

Publication Number Publication Date
JPWO2022230494A1 true JPWO2022230494A1 (https=) 2022-11-03
JP7817249B2 JP7817249B2 (ja) 2026-02-18

Family

ID=83847368

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2023517172A Active JP7817249B2 (ja) 2021-04-26 2022-03-25 免疫細胞の代謝促進用組成物

Country Status (7)

Country Link
US (1) US20240122899A1 (https=)
EP (1) EP4331582A4 (https=)
JP (1) JP7817249B2 (https=)
CN (1) CN117255683A (https=)
AU (1) AU2022265114A1 (https=)
TW (1) TW202308615A (https=)
WO (1) WO2022230494A1 (https=)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20230000829A1 (en) * 2019-10-28 2023-01-05 Suntory Holdings Limited Composition for sleep improvement comprising ergothioneine or salt thereof
JPWO2024172002A1 (https=) * 2023-02-16 2024-08-22
CN120640987A (zh) * 2023-02-16 2025-09-12 三得利控股株式会社 含有麦角硫因的更年期症状的预防或改善用组合物

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2012180329A (ja) * 2011-03-02 2012-09-20 Hokkaido Univ 抗微生物物質産生・分泌促進剤
JP2017218431A (ja) * 2016-06-09 2017-12-14 株式会社スリービー 免疫応答活性化サイトカイン産生促進剤およびTh17細胞分化促進剤

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6103746A (en) 1997-02-20 2000-08-15 Oxis International, Inc. Methods and compositions for the protection of mitochondria
US20020110604A1 (en) * 2000-08-11 2002-08-15 Ashni Naturaceuticals, Inc. Composition exhibiting synergistic antioxidant activity
JP5658479B2 (ja) 2009-04-27 2015-01-28 株式会社岩出菌学研究所 脂肪減少等の活性を示す組成物
CA2877861A1 (en) * 2012-06-26 2014-01-03 Entia Biosciences, Inc. A nutritional approach to improving athletic performance and reducing injury with l-ergothioneine and/or vitamin d2

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2012180329A (ja) * 2011-03-02 2012-09-20 Hokkaido Univ 抗微生物物質産生・分泌促進剤
JP2017218431A (ja) * 2016-06-09 2017-12-14 株式会社スリービー 免疫応答活性化サイトカイン産生促進剤およびTh17細胞分化促進剤

Also Published As

Publication number Publication date
WO2022230494A1 (ja) 2022-11-03
TW202308615A (zh) 2023-03-01
CN117255683A (zh) 2023-12-19
EP4331582A4 (en) 2025-04-09
AU2022265114A1 (en) 2023-10-12
JP7817249B2 (ja) 2026-02-18
EP4331582A1 (en) 2024-03-06
US20240122899A1 (en) 2024-04-18

Similar Documents

Publication Publication Date Title
BR112023005462A2 (https=)
BR112023012656A2 (https=)
BR112021014123A2 (https=)
BR112023009656A2 (https=)
BR112022009896A2 (https=)
JPWO2022230494A1 (https=)
JPWO2022230491A1 (https=)
BR112022024743A2 (https=)
BR112022026905A2 (https=)
BR112023011738A2 (https=)
BR112023004146A2 (https=)
BR112023006729A2 (https=)
BR102021018859A2 (https=)
BR102021007058A2 (https=)
BR102020022030A2 (https=)
BR112023016292A2 (https=)
BR112023011539A2 (https=)
BR112023011610A2 (https=)
BR112023008976A2 (https=)
BR102021020147A2 (https=)
BR102021018926A2 (https=)
BR102021018167A2 (https=)
BR102021014044A2 (https=)
BR102021014056A2 (https=)
BR102021012230A2 (https=)

Legal Events

Date Code Title Description
A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20240508

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20250603

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20250801

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20250925

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20260106

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20260205

R150 Certificate of patent or registration of utility model

Ref document number: 7817249

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150